![Avastin as effective as Eylea for treating central retinal vein occlusion | National Institutes of Health (NIH) Avastin as effective as Eylea for treating central retinal vein occlusion | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/styles/featured_media_breakpoint-medium/public/news-events/news-releases/2017/20170509-retina.jpg?itok=P_qEQcT1×tamp=1494343971)
Avastin as effective as Eylea for treating central retinal vein occlusion | National Institutes of Health (NIH)
![a) Pre-avastin diabetic macular edema with gross intraretinal fluid... | Download Scientific Diagram a) Pre-avastin diabetic macular edema with gross intraretinal fluid... | Download Scientific Diagram](https://www.researchgate.net/publication/5893647/figure/fig4/AS:202538574979075@1425300367248/a-Pre-avastin-diabetic-macular-edema-with-gross-intraretinal-fluid-horizontal-and.png)
a) Pre-avastin diabetic macular edema with gross intraretinal fluid... | Download Scientific Diagram
![Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy | Eye Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy | Eye](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.eye.6702983/MediaObjects/41433_2009_Article_BF6702983_Fig1_HTML.jpg)
Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy | Eye
![Intravitreal Injection of Bevacizumab (Avastin) as Adjunctive Treatment of Proliferative Diabetic Retinopathy - ScienceDirect Intravitreal Injection of Bevacizumab (Avastin) as Adjunctive Treatment of Proliferative Diabetic Retinopathy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002939406005551-gr1.jpg)
Intravitreal Injection of Bevacizumab (Avastin) as Adjunctive Treatment of Proliferative Diabetic Retinopathy - ScienceDirect
![Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy - ScienceDirect Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0161642006008554-gr1.jpg)
Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy - ScienceDirect
![PDF] Single-dose Intravitreal Bevacizumab after Complete Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: an Effective Adjunctive Treatment | Semantic Scholar PDF] Single-dose Intravitreal Bevacizumab after Complete Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: an Effective Adjunctive Treatment | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5911fe47b385e7d52de71a03b8f842c62229ac3b/3-Figure1-1.png)
PDF] Single-dose Intravitreal Bevacizumab after Complete Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: an Effective Adjunctive Treatment | Semantic Scholar
![Proliferative Diabetic Retinopathy - Optic Disc Neovascularization - Post Intravitreal Avastin Injections - The Retina Reference Proliferative Diabetic Retinopathy - Optic Disc Neovascularization - Post Intravitreal Avastin Injections - The Retina Reference](https://www.retinareference.com/diseases/beb00894be590ec0/images/46019c8a9e/image.jpg)
Proliferative Diabetic Retinopathy - Optic Disc Neovascularization - Post Intravitreal Avastin Injections - The Retina Reference
![Eylea outperforms other drugs for diabetic macular edema with moderate or worse vision loss | National Institutes of Health (NIH) Eylea outperforms other drugs for diabetic macular edema with moderate or worse vision loss | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/news-events/news-releases/2015/20150219-pupil.jpg)
Eylea outperforms other drugs for diabetic macular edema with moderate or worse vision loss | National Institutes of Health (NIH)
![PDF) Intravitreal bevacizumab (avastin) for proliferative diabetic retinopathy: 6-months follow-up | Juan Sánchez - Academia.edu PDF) Intravitreal bevacizumab (avastin) for proliferative diabetic retinopathy: 6-months follow-up | Juan Sánchez - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/45915331/mini_magick20190210-20768-17iqeo0.png?1549867365)
PDF) Intravitreal bevacizumab (avastin) for proliferative diabetic retinopathy: 6-months follow-up | Juan Sánchez - Academia.edu
![Bilateral improvement of persistent diffuse diabetic macular oedema after unilateral intravitreal bevacizumab (Avastin) injection | Eye Bilateral improvement of persistent diffuse diabetic macular oedema after unilateral intravitreal bevacizumab (Avastin) injection | Eye](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Feye.2008.162/MediaObjects/41433_2009_Article_BFeye2008162_Fig1_HTML.jpg)
Bilateral improvement of persistent diffuse diabetic macular oedema after unilateral intravitreal bevacizumab (Avastin) injection | Eye
![PDF) Tractional retinal detachment following intravitreal bevacizumab ( Avastin) in patients with severe proliferative diabetic retinopathy | Harry Flynn - Academia.edu PDF) Tractional retinal detachment following intravitreal bevacizumab ( Avastin) in patients with severe proliferative diabetic retinopathy | Harry Flynn - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/39898031/mini_magick20190222-12671-1sq7czh.png?1550840900)